SCHEMBL5496400

SCHEMBL5496400

CCCCC(N)CC(=O)O

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
S1PR2 O95136 3/20 0.57
S1PR1 P21453 3/20 0.57
ALDH1A1 P00352 1/20 0.52
GPR84 Q9NQS5 4/20 0.50
SLC1A2 P43004 2/20 0.47
SLC1A1 P43005 2/20 0.47
SLC1A3 P43003 1/20 0.47
CA2 P00918 2/20 0.45
MAPK1 P28482 1/20 0.45
CA1 P00915 1/20 0.43
ENPEP Q07075 2/20 0.42
S1PR3 Q99500 2/20 0.41
GRIK1 P39086 1/20 0.41
GRIK2 Q13002 1/20 0.41
S1PR4 O95977 1/20 0.41
DPP7 Q9UHL4 1/20 0.41
SLC15A1 P46059 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL288356 1.00 S1PR2 (0.57) S1PR2S1PR1ALDH1A1GPR84SLC1A2
SCHEMBL6466558 1.00 S1PR2 (0.57) S1PR2S1PR1ALDH1A1GPR84SLC1A2
SCHEMBL287826 0.93 S1PR2 (0.60) S1PR2S1PR1ALDH1A1GPR84SLC1A2
SCHEMBL626959 0.93 S1PR2 (0.60) S1PR2S1PR1ALDH1A1GPR84SLC1A2
SCHEMBL4411200 0.93 S1PR2 (0.60) S1PR2S1PR1ALDH1A1GPR84SLC1A2
SCHEMBL10804885 0.91 S1PR2 (0.63) S1PR2S1PR1ALDH1A1GPR84S1PR3
SCHEMBL22660994 0.91 S1PR2 (0.63) S1PR2S1PR1ALDH1A1GPR84S1PR3
SCHEMBL5419098 0.91 S1PR2 (0.63) S1PR2S1PR1ALDH1A1GPR84S1PR3
SCHEMBL11437074 0.91 S1PR2 (0.63) S1PR2S1PR1ALDH1A1GPR84S1PR3
SCHEMBL4390623 0.91 S1PR2 (0.63) S1PR2S1PR1ALDH1A1GPR84S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108218905-B Amino compound rubber additive and preparation and application thereof 同济大学 2020-03-24 CN claimed
EP-3008199-A1 TRANSAMINASE BIOCATALYSTS Commonwealth Scientific and Industrial Research Organisation (AU) 2016-04-20 EP claimed
CN-105452475-A Transaminase biocatalysts COMMW SCIENT IND RES ORG 2016-03-30 CN claimed
WO-2014197941-A1 TRANSAMINASE BIOCATALYSTS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2014-12-18 WO claimed
EP-1021528-B1 METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS INST GENETICS LLC (US) 2004-01-28 EP claimed
CN-1380064-A Method for producing antibiotic preparation and its application HERAEUS GUSA GMBH & CO KG (DE) 2002-11-20 CN claimed
US-20020052026-A1 METHODS OF REFOLDING PROTEINS GENETICS INSTITUTE, LLC 2002-05-02 US claimed
EP-1021528-A1 METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS GENETICS INSTITUTE, INC. (US) 2000-07-26 EP claimed
WO-1999018196-A1 METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS GENETICS INSTITUTE, INC. (US) 1999-04-15 WO claimed
US-12404419-B2 Imide addition-fragmentation agents 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-09-02 US disclosed
US-12398301-B2 Adhesives comprising cyclic imide addition-fragmentation and adhesion agents 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-08-26 US disclosed
US-12329833-B2 Dental compositions SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-06-17 US disclosed
CN-109790114-B Novel chiral ligand, metal chelate, various unnatural amino acids and synthesis method of maraviroc and key intermediate thereof 中国科学院上海药物研究所 2025-03-07 CN disclosed
US-20250069874-A1 APPARATUS AND METHOD FOR AGRICULTURAL CONTAMINANT DETECTION ARROWHEAD CENTER, INC. (US) 2025-02-27 US disclosed
EP-1243257-A1 Sustained release preparation comprising one or more antibiotics Heraeus Kulzer GmbH & Co.KG (DE) 2002-09-25 EP disclosed
EP-0555537-B1 Endothelin antagonists BANYU PHARMA CO LTD (JP) 2000-11-02 EP disclosed
US-5969095-A VARIATION OF AMINO ACID SEQUENCE FROM POSITION 1 TO 34; FOR TREATMENT OF OSTEOPOROSIS OR OTHER BONE DISORDERS; STIMULANTS OF OSTEOGENESIS BIOMEASURE, INC. (US) 1999-10-19 US disclosed
US-5614498-A OLIGOPEPTIDES, BRONCHDILATORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-03-25 US disclosed
US-5496928-A Endothelin antagonistic substance BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-03-05 US disclosed
EP-0555537-A2 Endothelin antagonistic substance BANYU PHARMACEUTICAL CO., LTD. (JP) 1993-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12329833-B2 Dental compositions ARCN1, EEF1D, EBP S1PR2 4384/4885S1PR1 4425/4885ALDH1A1 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.